Login | Register
Profile | Log out
logo

  • Home
  • News
  • Opinion
  • Other
    • Market Updates
    • Explainers
    • Satire
  • About
  • Contact Us
    • Contact
    • Get Covered
    • Posting Guidelines
  • Subscribe
Submit An Article

News

  • Home
  •  
  • News



  • Most Read
  • Latest Comments
  • Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test
    • News

    RBA and ASIC up the ante on blockchain project, ASX writes off millions
    Public
  • Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test
    • News

    Smart pain assessment app now used by more than half of Australia’s residential aged care providers
    Public
  • Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test
    • News

    Fledgling fintech hopes millennials put their Douugh into micro-investing ‘super’ app
    Public
  • Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test
    • News

    🎵 The knee bone’s connected to the… collagen rope device (?!)
    Public
  • Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test
    Opening a new frontier in treating Parkinson’s disease
    • Review
    • November 11, 2022
  • Tremors from the FTX collapse continue to be felt as DigitalX sells off 15% Bitcoin holdings
    • Review
    • January 10, 2023
  • AUDC stablecoin gathers momentum as Novatti confirms integration with XRP Ledger
    • Review
    • June 9, 2022
  • PharmAust completes dosing first cohort for MND treatment, patients respond positively
    • Review
    • January 6, 2023
  • Parkinson’s UK backs Pharmaxis with $5 million to slow the onset of incurable disease with ‘ground breaking’ trial
    • Review
    • September 1, 2022

Latest Articles

  • After TGA and Chairman fiasco, Rhythm Biosciences concedes no commercial sales are possible for its bowel cancer kits
    After TGA and Chairman fiasco, Rhythm Biosciences concedes no commercial sales are possible for its bowel cancer kits
    • News

  • Rhythm Biosciences nears commercialisation of revolutionary cancer test following filing of approval documents with the TGA
    Rhythm Biosciences nears commercialisation of revolutionary cancer test following filing of approval documents with the TGA
    • News

  • Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test
    Rhythm Biosciences’ new clinical trial shows increases accuracy for their simple cancer blood test
    • News

  • Top of the class: Rhythm’s latest study results outperform the standard
    Top of the class: Rhythm’s latest study results outperform the standard
    • News

  • Rhythm Biosciences appoint mass manufacturer for bowel cancer test kits
    Rhythm Biosciences appoint mass manufacturer for bowel cancer test kits
    • News

  • Cirrus continues record growth year, securing $5.5 million in WA Government contracts
    • News

    Cirrus continues record growth year, securing $5.5 million in WA Government contracts

    IT solutions provider Cirrus Network Holdings (ASX: CNW) has announced the awarding of two major contracts, both secured via public tender, to the figure of $5.5 million.  The securing of the contracts continue a strong run of sales for the Perth-based IT company which last month announced record (unaudited) EBITDA of $1.8 million and revenues

    Read More
    Public
  • AgTech producer RotoGro delivers $600k order to cannabis company
    • News

    AgTech producer RotoGro delivers $600k order to cannabis company

    Roto-Gro International Limited (ASX: RGO) has reported the delivery of a $600,000 order of their patented Hydroponic Rotational systems to Canadian cannabis company Oakum Cannabis.  The global produce market is expected to grow from $280 billion in 2017 to $295 billion in 2022. Increasing fruit and vegetable consumption is driven by a growing middle class

    Read More
    Public
  • Dicker Data rewards loyal staff with $1,000 of shares each
    • News

    Dicker Data rewards loyal staff with $1,000 of shares each

    IT product distributor Dicker Data (ASX: DDR)  has today announced they will issue $1,000 of free shares to eligible employees which continues a monumental rise for the company whose share price has risen from $2.80 at the start of 2019 to now be trading around $6 per share.  Such growth comes after a strong 2018Read More
    Expert
  • Top sports management firms TLA and Stride acquired by QMS Media for $32.7 million
    • News

    Top sports management firms TLA and Stride acquired by QMS Media for $32.7 million

    Australian media company QMS Media (ASX: QSM) has today announced the acquisition of leading sports management firm TLA Worldwide, as well as Stride Sports Management for $32.7 million.  The purchase will bring both management firms under the QMS Sport Holdings banner, a subsidiary of QMS Media. The acquisitions will advance QMS Sports as a global

    Read More
    Public
  • Jatenergy acquires major stake in ANMA, streamlining Aus-China infant formula production
    • News

    Jatenergy acquires major stake in ANMA, streamlining Aus-China infant formula production

    Australia-China trade specialist Jatenergy (ASX: JAT) has made a sizable splash in the infant formula market, today announcing the 70% acquisition of dairy product producer Australian Natural Milk Association (ANMA).  The acquisition will enable Jatenergy  to expand its manufacturing capabilities, which until now had outsourced the manufacturing of its dairy products.  “We are delighted to

    Read More
    Public
  • Cannabis producer announces record subscription numbers amidst global expansion
    • News

    Cannabis producer announces record subscription numbers amidst global expansion

    Medicinal cannabis company Althea Group Holdings (ASX:AGH) has announced record prescription numbers for their medicinal cannabis products in the month of July which has been consolidated by two major corporate partnerships.  Prescriptions of the Group’s medical cannabis products increased by 334 patients in the month, bringing the total to 1,523 for the company which listed

    Read More
    Public
  • Healthia expands national presence with NSW acquisitions
    • News

    Healthia expands national presence with NSW acquisitions

    Allied healthcare operator Healthia (ASX:HLA) has continued its clinic acquisition spree, this week announcing the addition of 4 hand therapy clinics in Sydney. Since listing on the ASX in September 2018, Healthia has now acquired 26 new clinics across it’s podiatry and physio businesses with the latest round of clinics forecast to deliver annual earnings

    Read More
    Public
  • Aussie bookmaker shares surge following major U.S partnership with Penn National Gaming
    • News

    Aussie bookmaker shares surge following major U.S partnership with Penn National Gaming

    In two short months since listed on the ASX, PointsBet Holdings Limited (ASX: PBH) has accelerated its activities in the lucrative U.S gaming market, today announcing a strategic partnership with Penn National Gaming (Nasdaq: PENN). Under the agreement, the Melbourne-based bookmaker has secured market access to West Virginia and Indiana where sports betting has been

    Read More
    Public
  • Community still unaware what a podiatrist offers, as Healthia continues expansion
    • News

    Community still unaware what a podiatrist offers, as Healthia continues expansion

    National healthcare operator Healthia (ASX: HLA) has continued its acquisition of podiatry clinics in what…

    Read More
    Public
  • NeuroScientific Biopharmaceuticals make major breakthrough towards treating Alzheimer’s
    • News

    NeuroScientific Biopharmaceuticals make major breakthrough towards treating Alzheimer’s

    With the average person’s life expectancy rising, Alzheimer’s disease is emerging as a major health concern which can have devastating effects on an individual’s cognitive function. It leads to progressive loss of brain cells which later leads to loss of memory and has become a global menace, costing the world over US$818 billion in treatment

    Read More
    Public
  • «
  • ‹
  • 313
  • 314
  • 315

Login or register for free to access unlimited reading

Register Now!
  • News

  • Opinion

  • Satire

  • About

  • Contact Us

  • Subscribe

The content published on this website is solely for general information purposes and is not to be construed as financial advice. Should you seek financial advice you should consult with an appropriately qualified person. Opinions expressed on this site are subject to change without notice and The Sentiment who produced this content is under no obligation to keep the information current. The Sentiment, affiliated companies & associates may have a conflict of interest with companies discussed on the website due to commercial arrangements, for example they may be shareholders in the company, be engaged by them to assist in investor communications or receive commission/brokerage for funds raised.

Copyright © 2020 The Sentiment. All rights reserved.
Subscribe

Enter your email address below to subscribe to The Sentiment’s weekly newsletter, highlighting the top news, research, opinion and satire articles shaping ASX investor sentiment.

The Sentiment respects your privacy and will not spam you. View our privacy policy here.